BOCA RATON, Fla., Feb. 6, 2025 /PRNewswire/ — Arkstone Medical Solutions is proud to announce a groundbreaking partnership with Neslab, a leading Peruvian medical technology company, to expand access to precision-guided infectious disease treatment across Peru. This collaboration will bring state-of-the-art antimicrobial stewardship tools and data-driven clinical insights to physicians nationwide, enhancing patient care while combating the global challenge of antimicrobial resistance (AMR).
By incorporating Arkstone’s OneChoice technology—which provides AI-enhanced clinical decision support and optimized treatment recommendations—with Neslab’s proprietary SIMCORE software platform, Peruvian healthcare professionals will gain access to real-time, evidence-based guidance. This initiative will facilitate seamless integration with public hospital information systems, ensuring a more effective, data-driven approach to antibiotic stewardship that reduces both inappropriate and unnecessary antibiotic use, ultimately improving patient outcomes.
“Most healthcare systems outside of the United States are predominantly government-managed,” said Steve Brennan, Global Partnerships Manager at Arkstone. “Our partnership with Neslab in Peru will allow us to reach a much broader patient population, far beyond private labs and clinics. This alliance reinforces our commitment to combating antimicrobial resistance on a global scale.”
“This partnership exemplifies our dedication to providing scalable solutions in the fight against antimicrobial resistance and bridging the gap in antimicrobial stewardship,” said Ari Frenkel, MD, MPH, Chief Science Officer of Arkstone.
“This alliance marks a turning point in Peruvian healthcare, uniting local expertise with cutting-edge international technology to improve the lives of millions,” said Martin Cuba, General Manager of Neslab. “We are pleased to welcome Arkstone as our strategic partner on this journey towards a healthier and technologically advanced future for all Peruvians.”
This collaboration underscores Arkstone’s mission to revolutionize infectious disease management, ensuring that healthcare providers across Peru have access to world-class clinical decision-support tools. With Neslab’s deep local expertise and Arkstone’s advanced technology, this partnership is set to reshape healthcare delivery and enhance patient outcomes throughout the country.
For more information, visit neslab.com.pe or www.arkstone.ai.
Media Contact:
Sol Levi
1-833-933-ARK-3
SOURCE Arkstone
After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…
Clemson University and Nordic Wellness have launched a pioneering partnership tackling the student mental health…
Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as…